MARKET WIRE NEWS
  1. Home
  2. Stock
  3. HALO
  4. News
HALO
Quote
Short
News
Articles
Message Board

Halozyme Therapeutics Inc. (NASDAQ : HALO ) News

Halozyme Therapeutics Inc. (NASDAQ: HALO) News Releases

HALO News Releases
HALO : NASDAQ
PR Newswire
U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma
HALO : NASDAQ
SeekingAlpha
J&J wins FDA nod for multiple myeloma therapy
HALO : NASDAQ
SeekingAlpha
Halozyme Therapeutics, Inc. (HALO) Presents at TD Cowen 46th Annual Health Care Conference Transcript
HALO : NASDAQ
PR Newswire
Halozyme to Participate in Upcoming Investor Conferences
HALO : NASDAQ
SeekingAlpha
Halozyme declines after Q4 bottom line miss, reiterates 2026 guidance
HALO : NASDAQ
SeekingAlpha
Halozyme Delivers Record FY2025 As 2026 Sets Up A Major Profitability Surge
HALO : NASDAQ
SeekingAlpha
Halozyme outlines $1.71B-$1.81B 2026 revenue target as new subcutaneous technologies expand pipeline
HALO : NASDAQ
SeekingAlpha
Halozyme Therapeutics, Inc. (HALO) Q4 2025 Earnings Call Transcript
HALO : NASDAQ
Motley Fool
Halozyme (HALO) Q4 2025 Earnings Call Transcript
HALO : NASDAQ
SeekingAlpha
Halozyme Therapeutics Non-GAAP EPS of -$0.24 misses by $2.44, revenue of $451M beats by $4.86M

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.